SNORA71B

Across TCGA pan-cancer cohorts, SNORA71B RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of SNORA71B’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where SNORA71B RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNORA71B is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

COAD, HNSC, and READ are the cancer types where SNORA71B tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNORA71B RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	IV	+1.748	<.001	12	view →
HNSC	Male	All	+0.607	<.001	8	view →
READ	Female	All	+1.964	<.001	7	view →
STAD	Male	II,III,IV	+1.118	<.001	5	view →
LUSC	Male	All	+0.655	<.001	4	view →
KIRC	All	All	+0.320	<.001	4	view →
CHOL	All	All	+1.771	<.001	3	view →
BLCA	All	III,IV	+0.875	.011	3	view →
LUAD	All	All	+0.666	<.001	3	view →
KICH	Female	All	+0.340	.021	3	view →
ESCA	All	All	+0.785	.031	2	view →
PRAD	All	All	+0.671	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

SNORA71B–COAD

Open the COAD breakdown →